RNA interference (RNAi) technology has been widely used in therapeutics development, especially multiple targeted RNAi strategy, which is a better method for multiple gene suppression. In the study, interfering RNAs (iRNAs) were designed for carrying two or three different siRNA sequences in different secondary structure formats (loop or cloverleaf). By using these types of iRNAs, co-inhibition of survivin and B-cell lymphoma-2 (Bcl-2) was investigated in hepatocellular carcinoma (HCC) cells, and we obtained promising gene silencing effects without showing undesirable interferon response. Furthermore, suppression effects on proliferation, invasion, and induced apoptosis in HCC cells were validated. The results suggest that long iRNAs with secondary structure may be a preferred strategy for multigenic disease therapy, especially for cancer and viral gene therapy and their iRNA drug development.
Introduction
RNA interference (RNAi) has shown tremendous potential in medicinal therapeutics development in past decade (1) (2) (3) (4) . Now, it has been confirmed that RNAi has great potential in treatment of various human diseases, such as viral infections (5, 6) , cancers (7-10) and orphan disease (11) . Recently, an attempt using a long double-strand siRNA was made, as an alternative way, to carry on multiple interfering RNAs (iRNA) for multiple gene suppression for treatment of many human diseases (12) (13) (14) , such as therapy for hepatocellular carcinoma (HCC) (10) . Currently there are more than thirty types of siRNA drug candidates entered into the stage of clinical trials (15) (16) (17) . However, these synthetic therapeutic long siRNA constructs in literature, including our previously study (18) , were all based on a primary structure format (linearlized). It is a well-known fact that the longer the RNA molecule is, the easer the degradation occurs during RNA processing in circulation or in cell level.
To stabilize long therapeutic RNA, in the study we first described a group of long synthetic iRNA with multiple siRNA targets in secondary structures (loop or cloverleaf) and applied them to HCC cells for multiple gene suppression.
Materials and methods
Cell lines and cell culture. SMMC-7721 was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml of penicillin and 100 µg/ml of streptomycin (all from Thermo Fisher Scientific, Waltham, MA, USA). These cell lines were purchased from the Institute of Cell Biology, Chinese Academy of Sciences, and cells were maintained at 37˚C with 5% CO 2 and 95% air in a humidified incubator.
Multi-target iRNA format design and transfection. The gene sequence of survivin (accession no. NM_001168) and B-cell lymphoma-2 (Bcl-2) (accession no. NM_000633.2) were obtained from National Center of Biotechnology Information (NCBI) GenBank (USA), and the single target siRNA (19 bp duplex with 2-nt 3'-overhangs) targeting either survivin or Bcl-2 were screened in our precious studies (Table I) (18, 19) . A double-stranded RNA sequence with no homology with human genes was designed as siRNA negative control (NC_ siR). All RNA oligonucleotides were synthesized by Biomics Biotechnologies Co., Ltd. (Nantong, China). The multi-target iRNA constructs targeting survivin and Bcl-2 were designed according to the principle of Biomics Biotechnologies Co., Ltd. (Table II) . The cells were transfected in vitro with siRNAs using Lipofectamine ® 2000 transfection reagent (Thermo Fisher Scientific) according to the instructions of the manufacturer. (20) .
Real-time quantitive PCR (RT-qPCR
Western blotting. Cells were plated in a 6-well plate at 1x10 6 cells/well and grown for 24 h until ~70-80% confluence. After cells were treated as described above for 48 h, they were harvested and lysed in RIPA buffer (Pierce, Rockford, IL, USA). Total protein was quantified by bicinchoninic acid (BCA) assay (Promega, Madison, WI, USA), and then ~20 µg of protein was separated by polyacrylamide gel electrophoresis (PAGE) and electroblotted onto polyvinylidine difluoride filter (PVDF) membranes (Millipore, Billerica, MA, USA), followed by blocking with 5% skim milk in TBST (20 mM Tris, 150 mM NaCl, 0.05% Tween-20, pH 7.5) buffer for 2 h at room temperature, then incubated with rabbit anti-human survivin antibody (1:500 dilution) and mouse anti-human Bcl-2 (1:500 dilution), mouse anti-human β-actin antibody (1:500 dilution) (all from Abcam, Cambridge, MA, USA) as internal control. The membranes were washed in TBST and incubated with a goat anti-rabbit or goat anti-mouse HRP-conjugated secondary antibody (1:1,000 dilution; Jackson Immunoresearch, West Grove, PA, USA) at room temperature for 2 h. Then, the specific proteins were detected with ECL chemiluminescence reagent (Beyotime, Beijing, China); the membranes were exposed to film (Kodak, Rochester, NY, USA).
Cell viability assay. MTT assay was used to measure the viability of cells. Cells were plated into a 96-well plate at 5x10 3 cells/well and grown for 24 h, then treated as above for 0, 24, 48, 72 and 96 h, 10 µl MTT (Beyotime) were added to each well of 96-well plate containing 100 µl DMEM medium and incubated at 37˚C for 4 h, then 150 µl/well DMSO was added and incubation was continue at 37˚C for 10 min. The optical density (OD) was measured at 490 nm using a Microplate Reader (Bio-Rad, Hercules, CA, USA).
Cell invasion assay. Cells were seeded into a 24-well plate at 2x10 4 cells/well and grown for 24 h, then treated as described above, post 48 h treament, cells were suspended in DMEM medium at the density of 1x10 6 Statistical analysis. All experiments were performed independently three times, the results are shown as mean ± standard deviation (SD), and statistical analyses were performed using SPSS 19.0 software. The differences were compared using Student's t-test and one way ANOVA followed by post hoc test to assess statistical significance. All P-values were based on a two-sided statistical analysis and P<0.05 was considered to indicate statistical significance.
Results
Designing different multi-target iRNAs. Multi-target iRNAs targeting survivin and Bcl-2 were designed according to different structure formats (Fig. 1) . The sense and antisense strands of iRNAs were synthesized by Biomics Biotechnologies Co., Ltd. and iRNAs were obtained after annealing of both strands (Table II and Fig. 1 ).
Inhibition effects of target genes in HCC cells by multi-target iRNAs.
The result of RT-qPCR and western blot analysis showed that, compared with untreated cell, the mRNA and protein level of survivin were both inhibited by survivin siRNA (S2 or S38). The mRNA and protein level of Bcl-2 were both inhibited by Bcl-2 siRNA (B2) (P<0.05) (Fig. 2) . Compared to untreated group, the mRNA level of survivin was inhibited by multi-target interfering RNAs (mtg_iRNA1), mtg_iRNA2 and mtg_iRNA3 up to 45, 27 and 53% (P<0.05) (Fig. 3A) ; the mRNA level of Bcl-2 was inhibited up to 38, 27 and 33% (P<0.05) (Fig. 3B) ; and there was no difference between NC_siRNA and untreated ones. Moreover, mtg_iRNA1, mtg_iRNA2 and mtg_iRNA3 showed no interferon response (Fig. 3C) . The protein level of survivin was inhibited by mtg_iRNA1, mtg_iRNA2 and mtg_iRNA3 up to 48, 46 and 68%, respectively (P<0.05); the protein level of Bcl-2 was inhibited up to 45, 57 and 48% (P<0.05), and there was no difference between NC_siR and untreated group (P>0.05) (Fig. 3D) .
Gene knockdown by mtg_iRNAs in an Ago2-dependent manner. Long double-stranded RNA was reported with gene knockdown effect in an Ago2-dependent manner (21) . To verify the manner of the effect of mtg_iRNAs, the Ago2 siRNA (sense, 5'-AAUCUCUUCUUGCCGAUCGdTdT-3' and antisense, 5'-CGAUCGGCAAGAAGAGAUUdTdT-3') was used to knockdown the expression of Ago2, and we further investigated whether mtg_iRNAs could downregulate the target genes. As shown in Fig. 3 , compared with untreated cells, the expression of Ago2 was inhibited efficiently by Ago2_siR, when Ago2 was downregulated, target gene survivin or Bcl-2 could not be inhibited by mtg_iRNAs, and thus gene knockdown by mtg_iRNAs was Ago2-dependent ( Fig. 3E) .
Inhibition effects on cell viability by multi-target siRNAs.
The viability of SMMC-7721 cells was measured by MTT assay. The absorbance values (490 nm) of the cells at 48, 72 and 96 h post-transfection with mtg_iRNA1, mtg_iRNA2 and mtg_iRNA3 were significantly lower than those of NC_siR treated and untreated cells, respectively (P<0.05) (Fig. 4) . There was no significant difference between NC_siR treated and untreated cells (P>0.05).
Inhibition effects on cell invasion by multi-target siRNAs.
The cell invasion abilities with different treatments were detected by Transwell assay, the result showed that the invasion of the cells treated with mtg_iRNA1, mtg_iRNA2 and mtg_iRNA3 were inhibited significantly post 48 h transfection (P<0.05). There was no significant difference of inhibition abilities between NC_siR and untreated cells (P>0.05) (Fig. 5) .
Cell apoptosis induces multi-target siRNAs. Annexin V-FITC/ PI double staining and FCM analysis were used to detect the ability of mtg_iRNAs on inducing SMMC-7721 cell apoptosis. The result showed that cells treated with mtg_iRNA1, 20.52±0.81%, mtg_iRNA2, 22.36±1.15% and mtg_iRNA3, 38.79±1.63% resulted in a significant increase of apoptosis compared with that of NC_siR treated cells, 1.96±1.35% and untreated cells, 1.52±1.41% (P<0.05) (Fig. 6 ).
Discussion
The present study is the first attempt to use long synthetic iRNA formats (loop or cloverleaf) to carry multiple siRNA targets. Survivin and Bcl-2 were used as HCC therapeutic targets in our study for iRNA therapeutics development. survivin is an apoptosis inhibitor that is expressed during the G2/M phase of the cell cycle and it is a member of the inhibitor of apoptosis (IAP) gene family, survivin encodes negative regulatory proteins that prevent apoptotic cell death (25) . Bcl-2 is specifically considered as an important anti-apoptotic oncogene, and it is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (26, 27) .
The efficiency of gene co-inhibition by long secondary structure iRNA was demonstrated (Fig. 3A, B and D) , in which all three mtg_iRNAs inhibited target genes (survivin or Bcl-2) effectively in both mRNA and protein level.
The side-effect of undesired interferon response caused long double-stranded RNA (dsRNA) is a major concern. It was addressed by a previous study indicating that specific gene knockdown via RNAi triggered by long dsRNA could induce interferon response (28) , thus the expression of OAS1 and IFIT1 were detected to monitor the interferon response and a synthetic dsRNA analog-poly(I:C) was used as positive control (29) . The designed long secondary structure iRNAs here had no obvious interferon response in mammalian cells (Fig. 3C) . RNAi effects can be triggered by different structural modifications of siRNA, also long multi-target based siRNA structures designed as Dicer substrates have been developed in therapeutic research (19) , and these siRNAs were all Ago2-dependent. In the present study, also our mtg_iRNAs were all Ago2-dependent by the method of Ago2 downregulation first (Fig. 3E ). Furthermore, we demonstrated that the proliferation and invasion of HCC cells were inhibited, also cell apoptosis was promoted by mtg_iRNAs effectively ( Fig. 4-6) . The results of this study demonstrated that the designed mtg_iRNAs construct had RNAi activities on knockdown target genes simultaneously. The results showed that, mtg_iRNAs may be a preferred strategy for multigenic disease therapy, especially in cancer.
In conclusion, the long iRNA with different formats (loop and cloverleaf) showed initial multi-gene co-inhibition effects without showing side-effect of interferon 
